Marveh Rahmati

7PUBLICATIONS
15CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedMolecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2023
Inhibition of IRE1 RNase activity modulates tumor cell progression and enhances the response to chemotherapy in colorectal cancer.

Sana Abbasi, Helia Rivand, Fatemeh Eshaghi

|Oct 13, 2021
The Role of BiP and the IRE1α-XBP1 Axis in Rhabdomyosarcoma Pathology.

Mahmoud Aghaei, Ahmad Nasimian, Marveh Rahmati

|Oct 09, 2020
New insights on the role of autophagy in the pathogenesis and treatment of melanoma.

Marveh Rahmati, Shiva Ebrahim, Saadeh Hashemi

|Aug 01, 2020
Combination therapy with TiO2 nanoparticles and cisplatin enhances chemotherapy response in murine melanoma models.

R Adibzadeh, M S Golhin, S Sari

|May 07, 2020
Expression of Diverse Angiogenesis Factor in Different Stages of the 4T1 Tumor as a Mouse Model of Triple-Negative Breast Cancer.

Saba Malekian, Marveh Rahmati, Soyar Sari

Pageof 2